Waters Corporation Appoints Wei Jiang to Board of Directors
June 24 2021 - 7:00AM
Business Wire
Waters Corporation (NYSE: WAT) today announced the appointment
of Wei Jiang to its Board of Directors, effective July 14, 2021.
Mr. Jiang currently serves as Executive Vice President and
President, Bayer Pharmaceuticals Region China & APAC and
President, Bayer Group Greater China.
Dr. Flemming Ornskov, Chairman of the Board, said, “We are
excited to welcome Wei to the Board and know that we will benefit
from his operating experience and transformation expertise. Wei has
an outstanding record of driving results in regions that represent
key growth opportunities for Waters, including China and other
Asia-Pacific markets. We believe he is a valuable addition to the
Board at this pivotal time for Waters.”
Dr. Udit Batra, President and Chief Executive Officer of Waters
Corporation, commented, “Wei’s results-driven experience will bring
perspective to the Board that directly aligns with Waters’ strategy
to accelerate growth and innovation. We look forward to his
insights as we continue to further strengthen our focus on serving
customers in the fast-growing and cutting-edge pharma market in
Greater China and beyond.”
Mr. Jiang said, “China’s pharma, biopharma and natural products
markets are experiencing a surge in growth and innovation. I can’t
think of a company better positioned than Waters to serve these
customers with the world-class analytical technologies and services
that Waters is so well known for. I am honored to join the Board
and contribute to the momentum of the Company’s ongoing
transformation.”
Mr. Jiang is Executive Vice President and President, Bayer
Pharmaceuticals Region China & APAC and President, Bayer Group
Greater China, where he is a Member of Pharmaceuticals Executive
Committee and responsible for pharma business in China and APAC. He
previously held various senior positions at AstraZeneca,
culminating in his role as Senior Vice President, China operations.
Prior to that, Mr. Jiang served as Managing Director, China
operations at Guidant Corporation and in various roles at Eli Lilly
& Company including Marketing Director, China Operations. He
currently serves on the boards of China Red Cross and R&D Based
Pharmaceuticals association. He received his undergraduate degree
in economics and finance at Indiana State University and a B.BA. in
business administration and finance from Campbell University in
North Carolina.
Additional Resources
- Waters Board of Directors
- Connect with Waters via Twitter, Facebook and LinkedIn
About Waters
Waters Corporation (NYSE:WAT), the world's leading specialty
measurement company, has pioneered chromatography, mass
spectrometry, and thermal analysis innovations serving the life,
materials, food and environmental sciences for more than 60 years.
With more than 7,400 employees worldwide, Waters operates directly
in 35 countries, including 14 manufacturing facilities, and with
products available in more than 100 countries.
Cautionary Statement
This release contains “forward-looking” statements regarding
future results and events, including statements regarding Mr.
Jiang’s appointment. For this purpose, any statements that are not
statements of historical fact may be deemed forward-looking
statements. Without limiting the foregoing, the words “will,”
“feels”, “believes”, “anticipates”, “plans”, “expects”, “intends”,
“suggests”, “appears”, “estimates”, “projects”, and similar
expressions, whether in the negative or affirmative, are intended
to identify forward-looking statements. Actual future results and
events may differ significantly from the results and events
discussed in the forward-looking statements within this release for
a variety of reasons, including the factors that are discussed in
the sections entitled “Forward-Looking Statements” and “Risk
Factors” of the Company’s annual report on Form 10-K for the year
ended December 31, 2020 as filed with the Securities and Exchange
Commission (“SEC”), as updated by the Company’s subsequent filings
with the SEC. The forward-looking statements included in this
release represent the Company’s estimates or views as of the date
of this release and should not be relied upon as representing the
Company’s estimates or views as of any date subsequent to the date
of this release. Except as required by law, the Company does not
assume any obligation to update any forward-looking
statements.”
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210624005162/en/
Waters Corporation Bryan Brokmeier, +1 508-482-3448 Senior
Director Investor Relations investor_relations@waters.com
Waters Corporation Kevin Kempskie, +1 508-482-2814 Senior
Director Public Relations pr@waters.com
Waters (NYSE:WAT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Waters (NYSE:WAT)
Historical Stock Chart
From Apr 2023 to Apr 2024